Boothbay Fund Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,384,465
| Closed | -$11M | – | 1497 |
|
|
2025
Q1 | $11M | Sell |
1,384,465
-4,038
| -0.3% | -$32.1K | 0.29% | 43 |
|
|
2024
Q4 | $7.54M | Buy |
+1,388,503
| New | +$7.54M | 0.19% | 130 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1676 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1623 |
|
|
2023
Q1 | – | Sell |
-11,601
| Closed | -$442K | – | 2148 |
|
|
2022
Q4 | $442K | Sell |
11,601
-14,812
| -56% | -$565K | 0.01% | 1022 |
|
|
2022
Q3 | $1.03M | Buy |
+26,413
| New | +$1.03M | 0.03% | 747 |
|
|
2022
Q2 | – | Sell |
-30,593
| Closed | -$1.01M | – | 2267 |
|
|
2022
Q1 | $1.01M | Buy |
+30,593
| New | +$1.01M | 0.02% | 713 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 1911 |
|
|
2021
Q2 | – | Sell |
-10,621
| Closed | -$795K | – | 1887 |
|
|
2021
Q1 | $795K | Buy |
10,621
+2,957
| +39% | +$221K | 0.03% | 579 |
|
|
2020
Q4 | $663K | Sell |
7,664
-6,370
| -45% | -$551K | 0.02% | 529 |
|
|
2020
Q3 | $858K | Sell |
14,034
-10,175
| -42% | -$622K | 0.05% | 410 |
|
|
2020
Q2 | $1.01M | Buy |
24,209
+3,096
| +15% | +$129K | 0.07% | 314 |
|
|
2020
Q1 | $606K | Sell |
21,113
-1,570
| -7% | -$45.1K | 0.05% | 356 |
|
|
2019
Q4 | $1.64M | Buy |
+22,683
| New | +$1.64M | 0.14% | 165 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 794 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 775 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 774 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 768 |
|
|
2018
Q3 | – | Sell |
-2,278
| Closed | -$357K | – | 809 |
|
|
2018
Q2 | $357K | Sell |
2,278
-1,457
| -39% | -$228K | 0.03% | 319 |
|
|
2018
Q1 | $602K | Sell |
3,735
-173
| -4% | -$27.9K | 0.07% | 209 |
|
|
2017
Q4 | $644K | Buy |
+3,908
| New | +$644K | 0.09% | 163 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 673 |
|